- Home
- SXTC
as of 12-10-2025 2:53pm EST
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
| Founded: | 2005 | Country: | China |
| Employees: | N/A | City: | N/A |
| Market Cap: | 184.5M | IPO Year: | 2019 |
| Target Price: | N/A | AVG Volume (30 days): | 224.1K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.32 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.95 - $7.84 | Next Earning Date: | 01-01-0001 |
| Revenue: | $1,740,907 | Revenue Growth: | -9.73% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Compare SXTC vs Leading Stocks
See how SXTC stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "SXTC China SXT Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.